MR angiography of aortoiliac occlusive disease: A phase III study of the safety and effectiveness of the blood-pool contrast agent MS-325

Radiology

Volumn 236, Issue 3, 2005, Pages 825-833

  Goyen, Mathias ^a,n   Edelman, Mark ^b   Perreault, Pierre ^c   O'Riordan, Elaine ^d   Bertoni, Hernan ^e   Taylor, James ^f   Siragusa, Daniel ^g   Sharafuddin, Melhem ^h   Mohler III, Emile R ⁱ   Breger, Robert ^j   Yucel, E Kent ^k   Shamsi, Kohkan ^l   Weisskoff, Robert M ^m  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b RUSH NORTH SHORE MEDICAL CENTER   (United States)

^c UNIVERSITY OF MONTREAL   (Canada)

^d LONDON HEALTH SCIENCES CENTRE   (Canada)

^e HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

^f ROYAL ADELAIDE HOSPITAL   (Australia)

^g UNIVERSITY OF FLORIDA HEALTH JACKSONVILLE   (United States)

^h UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

ⁱ UNIVERSITY OF PENNSYLVANIA   (United States)

^j ST LUKE S MEDICAL CENTER   (United States)

^k BRIGHAM AND WOMEN S HOSPITAL   (United States)

^l BAYER PHARMA AG   (Germany)

^m EPIX Pharmaceuticals   (United States)

ⁿ UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GADOFOSVESET; UNCLASSIFIED DRUG;

ADULT; AGED; ANAPHYLAXIS; ARTERY OCCLUSION; ARTICLE; BURNING SENSATION; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HYPERGLYCEMIA; IMAGE QUALITY; LERICHE SYNDROME; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; NAUSEA; PARESTHESIA; PERIPHERAL VASCULAR DISEASE; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PRURITUS; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGRAPHY; AORTIC DISEASES; ARTERIAL OCCLUSIVE DISEASES; CONTRAST MEDIA; FEMALE; GADOLINIUM; HUMANS; ILIAC ARTERY; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; PROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 23844477876     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2363040577     Document Type: Article

References (30)

1. Shehadi WH. Contrast media adverse reactions: occurrence, recurrence, and distribution patterns. Radiology 1982;143:11-17.
2. AbuRahma AF, Robinson PA, Boland JP, et al. Complications of arteriography in a recent series of 707 cases: factors affecting outcome. Ann Vasc Surg 1993;7:122-129.
3. Prince MR, Yucel EK, Kaufman JA, Harrison DC, Geller SC. Dynamic gadolinium-enhanced three-dimensional abdominal MR arteriography. J Magn Reson Imaging 1993;3:877-881.
4. Prince MR, Narasimham DL, Stanley JC, et al. Breath-hold gadolinium-enhanced MR angiography of the abdominal aorta and its major branches. Radiology 1995;197:785-792.
5. Prince MR, Schoenberg SO, Ward JS, Londy FJ, Wakefield TW, Stanley JC. Hemodynamically significant atherosclerotic renal artery stenosis: MR angiographic features. Radiology 1997;205:128-136.
6. Krinsky GA, Rofsky NM, DeCorato DR, et al. Thoracic aorta: comparison of gadolinium-enhanced three-dimensional MR angiography with conventional MR imaging. Radiology 1997;202:183-193.
7. Meaney JF, Weg JG, Chenevert TL, Stafford-Johnson D, Hamilton BH, Prince MR. Diagnosis of pulmonary embolism with magnetic resonance angiography. N Engl J Med 1997;336:1422-1427.
8. Meaney JF, Prince MR, Nostrant TT, Stanley JC. Gadolinium-enhanced MR angiography of visceral arteries in patients with suspected chronic mesenteric ischemia. J Magn Reson Imaging 1997;7:171-176.
9. Ho KY, Leiner T, de Haan MW, Kessels AG, Kitslaar PJ, van Engelshoven JM. Peripheral vascular tree stenoses: evaluation with moving-bed infusion-tracking MR angiography. Radiology 1998;206:683-692.
10. Snidow JJ, Aisen AM, Harris VJ, et al. Iliac artery MR angiography: comparison of three-dimensional gadolinium-enhanced and two-dimensional time-of-flight techniques. Radiology 1995;196:371-378.
11. Hany TF, Debatin JF, Leung DA, Pfammatter T. Evaluation of the aortoiliac and renal arteries: comparison of breath-hold, contrast-enhanced, three-dimensional MR angiography with conventional catheter angiography. Radiology 1997;204:357-362.
12. OptiMark [package insert]. St Louis, Mo: Mallinckrodt, 2003.
13. Prince MR, Arnoldus C, Frisoli JK. Nephrotoxicity of high-dose gadolinium compared with iodinated contrast. J Magn Reson Imaging 1996;6:162-166.
14. Lauffer RB, Parmelee DJ, Dunham SU, et al. MS-325: albumin-targeted contrast agent for MR angiography. Radiology 1998;207:529-538.
15. Parmelee DJ, Walovitch RC, Ouellet HS, Lauffer RB. Preclinical evaluation of the pharmacokinetics, biodistribution, and elimination of MS-325, a blood pool agent for magnetic resonance imaging. Invest Radiol 1997;32:741-747.
16. Grist TM, Korosec FR, Peters DC, et al. Steady-state and dynamic MR angiography with MS-325: initial experience in humans. Radiology 1998;207:539-544.
17. Perreault P, Edelman MA, Baum RA, Mohler E. MR angiography with gadofosveset trisodium for peripheral vascular disease: phase II trial. Radiology 2003;229: 811-820.
18. Swets JA, Pickett RM. Evaluation of diagnostic systems: methods for signal detection. New York, NY: Academic Press, 1982.
19. Eliasziw M, Donner A. Application of the McNemar test to non-independent matched pair data. Stat Med 1991;10:1981-1991.
20. Naganawa S, Koshikawa T, Kato K, et al. Aortoiliac stenooculusive disease and aneurysms: screening with non-contrast enhanced two-dimensional cardiac gated cine phase contrast MR angiography with multiple velocity encoded values and cardiac gated two-dimensional time-of-flight MR angiography. Radiat Med 2001;19:99-105.
21. Pipe JG. Limits of time-of-flight magnetic resonance angiography. Top Magn Reson Imaging 2001;12:163-174.
22. Nielsen HT, Gold GE, Olcott EW, Pauly JM, Nishimura DG. Ultra-short echo-time 2D time-of-flight MR angiography using a half-pulse excitation. Magn Reson Med 1999;41:591-599.
23. Quinn SF, Sheley RC, Semonsen KG, Leonardo VJ, Kojima K, Szumowski J. Aortic and lower-extremity arterial disease: evaluation with MR angiography versus conventional angiography. Radiology 1998;206:693-701.
24. Goyen M, Herborn CU, Kroger K, Lauenstein TC, Debatin JF, Ruehm SG. Detection of atherosclerosis: systemic imaging for systemic disease with whole-body three-dimensional MR angiography-initial experience. Radiology 2003;227:277-282.
25. Barkhausen J, Quick HH, Lauenstein T, et al. Whole-body MR imaging in 30 seconds with real-time true FISP and a continuously rolling table platform: feasibility study. Radiology 2001;220:252-256.
26. Goyen M, Quick HH, Debatin JF, et al. Whole-body three-dimensional MR angiography with a rolling table platform: initial clinical experience. Radiology 2002; 224:270-277.
27. Archie JP. Analysis and comparison of pressure gradients and ratios for predicting iliac stenosis. Ann Vasc Surg 1994;8:271-280.
28. Barber GG, Fong H, McPhail NV, Scobie TK. Hemodynamic assessment of the aortoiliac segment: a prospective study. Can J Surg 1980;23:542-544.
29. Flanigan DP, Pratt DG, Goodreau JJ, Burnham SJ, Yao JS, Bergan JJ. Hemodynamic and angiographic guidelines in selection of patients for femorofemoral bypass. Arch Surg 1978;113:1257-1262.
30. Udoff EJ, Earth KH, Harrington DP, Kaufman SL, White RI. Hemodynamic significance of iliac artery stenosis: pressure measurements during angiography. Radiology 1979;132:289-293.